Tamoxifen in early breast cancer.
J R
JR
Benson
D016588:Anticarcinogenic Agents / Q000627:therapeutic use; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000517:prevention & control; D017024:Chemotherapy, Adjuvant; D018450:Disease Progression; D004965:Estrogen Antagonists / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D009364:Neoplasm Recurrence, Local; D011230:Precancerous Conditions / Q000473:pathology / Q000517:prevention & control; D011960:Receptors, Estrogen / Q000032:analysis; D015996:Survival Rate; D013629:Tamoxifen / Q000627:therapeutic use*; D016212:Transforming Growth Factor beta / Q000032:analysis
D016588:Anticarcinogenic Agents; D018931:Antineoplastic Agents, Hormonal; D004965:Estrogen Antagonists; D011960:Receptors, Estrogen; D016212:Transforming Growth Factor beta; D013629:Tamoxifen